Immediate treatment with bicalutamide 150mg as adjuvant therapy significantly reduces the risk of PSA progression in early prostate cancer (Q44628088)
Jump to navigation
Jump to search
scientific article published in November 2003
Language | Label | Description | Also known as |
---|---|---|---|
English | Immediate treatment with bicalutamide 150mg as adjuvant therapy significantly reduces the risk of PSA progression in early prostate cancer |
scientific article published in November 2003 |
Statements
1 reference
Immediate treatment with bicalutamide 150mg as adjuvant therapy significantly reduces the risk of PSA progression in early prostate cancer (English)
1 reference
See W
1 reference
Iversen P
1 reference
Wirth M
1 reference
McLeod D
1 reference
Garside L
1 reference
Morris T
1 reference
1 November 2003
1 reference
1 reference
44
1 reference
5
1 reference
512-7; discussion 517-8
1 reference
Identifiers
1 reference
1 reference